Company Overview and News


Add CDXC
to your dashboard

Headline News

The Interesting Company That Produces An Anti-Aging Pill

2017-11-14 seekingalpha
ChromaDex has a product that can has multiple health benefits, including resistance to weight gain, improved control of blood sugar and cholesterol, reduced nerve damage, and longer lifespan. (79-0)

ChromaDex's (CDXC) CEO Frank Jaksch on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Ladies and gentlemen, thank you for standing by, and welcome to the ChromaDex Corporation Third Quarter 2017 Earnings Conference Call. My name is Brian, and I will be the conference operator today. [Operator Instructions]. (6-0)

Billionaires Club Investing In ChromaDex As Revenue Grows

2017-11-10 seekingalpha
Recent change in company strategy includes sale of their lab business and more focus on Niagen (NR) sales. (147-3)

CDXC / ChromaDex Corporation - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-07 fintel.io
ChromaDex Corporation (NASDAQ:CDXC) has 48 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16,945,026 shares. Largest shareholders include Champion River Ventures Ltd, Pioneer Step Holdings Ltd, Frost Phillip Md Et Al, Vanguard Group Inc, and Tieton Capital Management, LLC. (6-0)

BRIEF-Chromadex announces $23 mln private placement of common stock

2017-11-06 reuters
* Chromadex Corp - in connection with investment, co agreed to sell 5.6 million shares of common stock at a per share price of $4.10​ (6-1)

BRIEF-Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 mln

2017-10-31 reuters
* Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 million - SEC filing Source text: [bit.ly/2z2cq3P] Further company coverage: (6-0)

BRIEF-Chromadex appoints Kevin Farr as new CFO

2017-10-09 reuters
* Chromadex Corp says ‍Chromadex expects that Thomas Varvaro will transition from Chromadex over coming months to pursue other opportunities​ Source text for Eikon: Further company coverage: (6-0)

ChromaDex's (CDXC) CEO Frank Jaksch on Q2 2017 Results - Earnings Call Transcript

2017-08-11 seekingalpha
Ladies and gentlemen thank you for standing by and welcome to the ChromaDex Corporation's Second Quarter 2017 Earnings Conference Call. My name is Vince, and I'll be the conference operator today.

ChromaDex: New Cash, New Strategy: Will Success Follow?

2017-07-25 seekingalpha
Near-term, investors are looking for progress and updates on new marketing strategy, which could shake up the income statement.

BRIEF-Chromadex says files for resale of up to 7.65 mln shares by selling stockholders

2017-06-09 reuters
* Chromadex Corp files for resale from time to time of up to 7.65 million shares of co's common stock by the selling stockholders - SEC filing Source text - bit.ly/2rK2K9T Further company coverage:

ChromaDex's (CDXC) CEO Frank Jaksch on Q1 2017 Results - Earnings Call Transcript

2017-05-12 seekingalpha
Ladies and gentlemen thank you for standing by and welcome to the ChromaDex Corporation’s First Quarter 2017 Earnings Conference Call. My name is Karen, and I’ll be the conference operator today.

CenturyLink Inc (CTL), Tripadvisor Inc (TRIP) Lead 17 Notable Investor Filings

2017-05-09 investorplace
There were 17 notable investor filings today. CenturyLink Inc (NYSE:CTL) is the largest company of interest. (0-1)

CUSIP: 171077407